Get started
Author

Joanna Obacz

Inhibition of IRE1 RNase activity modulates the tumor cell secretome and enhances response to chemotherapy
2018 · Susan E. Logue, Eoghan P. McGrath, et al. · Nature Communications · 283
PDF
Dual IRE1 RNase functions dictate glioblastoma development
2018 · Stéphanie Lhomond, Tony Avril, et al. · EMBO Molecular Medicine · 176
PDF
Endoplasmic reticulum proteostasis in glioblastoma—From molecular mechanisms to therapeutic perspectives
2017 · Joanna Obacz, Tony Avril, et al. · Science Signaling · 139
Inhibition of METTL3 Results in a Cell-Intrinsic Interferon Response That Enhances Antitumor Immunity
2023 · Andrew A. Guirguis, Yaara Ofir-Rosenfeld, et al. · Cancer Discovery · 131
Control of anterior GRadient 2 (AGR2) dimerization links endoplasmic reticulum proteostasis to inflammation
2019 · Marion Maurel, Joanna Obacz, et al. · EMBO Molecular Medicine · 89
PDF
Cross-talk between HIF and p53 as mediators of molecular responses to physiological and genotoxic stresses
2013 · Joanna Obacz, Silvia Pastorekova, et al. · Molecular Cancer · 89
PDF
Regulation of tumor–stroma interactions by the unfolded protein response
2017 · Joanna Obacz, Tony Avril, et al. · FEBS Journal · 56
The role of AGR2 and AGR3 in cancer: Similar but not identical
2015 · Joanna Obacz, Martina Takacova, et al. · European Journal of Cell Biology · 56
CD90 Expression Controls Migration and Predicts Dasatinib Response in Glioblastoma
2017 · Tony Avril, Amandine Etcheverry, et al. · Clinical Cancer Research · 50
Enhancing Drug Delivery Efficacy Through Bilayer Coating of Zirconium-Based Metal–Organic Frameworks: Sustained Release and Improved Chemical Stability and Cellular Uptake for Cancer Therapy
2024 · Xiewen Liu, Joanna Obacz, et al. · Chemistry of Materials · 40
Use of preclinical models for malignant pleural mesothelioma
2021 · Marie Shamseddin, Joanna Obacz, et al. · Thorax · 32
PDF
Biological basis for novel mesothelioma therapies
2021 · Joanna Obacz, Henry Yung, et al. · British Journal of Cancer · 31
PDF
IRE1 endoribonuclease signaling promotes myeloid cell infiltration in glioblastoma
2023 · Joanna Obacz, Jérôme Archambeau, et al. · Neuro-Oncology · 25
PDF
Extracellular AGR3 regulates breast cancer cells migration via Src signaling
2019 · Joanna Obacz, Lucia Sommerova, et al. · Oncology Letters · 23
PDF
Anterior gradient protein 3 is associated with less aggressive tumors and better outcome of breast cancer patients
2015 · Roman Hrstka, Joanna Obacz, et al. · OncoTargets and Therapy · 23
PDF
Tamoxifen-Dependent Induction of AGR2 Is Associated with Increased Aggressiveness of Endometrial Cancer Cells
2017 · Roman Hrstka, Jan Podhorec, et al. · Cancer Investigation · 19
Single-cell transcriptomic analysis of human pleura reveals stromal heterogeneity and informs in vitro models of mesothelioma
2024 · Joanna Obacz, Jose Antonio Valer, et al. · European Respiratory Journal · 16
PDF
Dual IRE1 RNase functions dictate glioblastoma development
2022 · Stéphanie Lhomond, Tony Avril, et al. · EMBO Molecular Medicine · 15
Erratum To: Dual IRE1 RNase functions dictate glioblastoma development
2023 · Stéphanie Lhomond, Tony Avril, et al. · EMBO Molecular Medicine · 6
Novel IRE1-dependent proinflammatory signaling controls tumor infiltration by myeloid cells
2019 · Joanna Obacz, Jérôme Archambeau, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 6
PDF
Inhibition of METTL3 by STC-15 induces RNA misprocessing that results in dsRNA formation and activates innate immunity
2025 · Harry Fischl, Tamsin J Samuels, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 5
Data from Inhibition of METTL3 Results in a Cell-Intrinsic Interferon Response That Enhances Antitumor Immunity
2023 · Andrew A. Guirguis, Yaara Ofir-Rosenfeld, et al. · 2
Abstract C077: STC-15, a small molecule inhibitor of the RNA methyltransferase METTL3, activates anti-tumor immunity and reshapes the tumor microenvironment
2023 · Yaara Ofir-Rosenfeld, Lina Vasiliauskaitė, et al. · Molecular Cancer Therapeutics · 1
Single-cell transcriptomic analysis of human pleura reveals stromal heterogeneity and informs in vitro models of mesothelioma
2022 · Joanna Obacz, Reshma Nibhani, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1
PDF
Abstract 3053: Combination of the MDM2 antagonist ASTX295 and Olaparib as a novel treatment option for BRCA2 mutant, TP53 wild-type solid tumors
2026 · Antonio Morales, Joanna Obacz, et al. · Cancer Research
Works count: 124
Citation count: 1,314
H-index: 16
I10-index: 18
Year
Topic
Type